PRAMOMOLECULAR is at the forefront of synthetic biology, developing revolutionary therapies that harness the power of gene silencing to treat diseases such as cancer. The company is focusing on creating novel siRNA therapeutics that can target and downregulate disease-causing proteins, providing a new mode of action in the fight against some of the most challenging diseases. With a strong focus on improving the precision and efficiency of drug development, PRAMOMOLECULAR is poised to change the landscape of healthcare.
The company’s founding was deeply personal for its founder, who lost his father to pancreatic cancer. This experience fueled his commitment to developing more effective treatments for cancer, with a focus on reducing side effects and improving patient outcomes. As he explains, “Our technology utilizes transport molecules that are protected by international patent applications to carry out Gene Silencing in selected tissues particularly efficiently. Unlike others, our siRNAs do not need to be packaged in nanoparticles – not even to prevent immune reactions or to stabilize them.”
PRAMOMOLECULAR’s innovative approach to drug development could revolutionize the way we treat not only cancer but also other diseases with high medical needs. The company’s ability to develop therapies more quickly and at a fraction of the cost of traditional methods has the potential to significantly improve the speed and accessibility of life-saving treatments.
Deep Tech for a Better Tomorrow
The finalists of the Deep Tech Award 2025 are shining examples of how innovation can be harnessed to tackle some of the most critical challenges facing our world. Whether it’s regenerating ecosystems with Skyseed, empowering social change with Level Nine Labs, or transforming healthcare with PRAMOMOLECULAR, these companies are using deep tech to create sustainable solutions that have the potential to change the world for the better. Their work not only demonstrates the immense potential of technology but also shows how it can be used responsibly to address pressing global issues, ensuring a better tomorrow for all.